Ting Tao

发表

The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma

A. Look, T. Tao, S. Baserga, 2017, Oncogene.

Def defines a conserved nucleolar pathway that leads p53 to proteasome-independent degradation

D. Lane, Jinrong Peng, Jun Chen, 2013, Cell Research.

LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.

Hu Li, D. Neuberg, A. Look, 2017, Cancer cell.

Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation.

Hu Li, A. Look, C. Ung, 2017, Cell reports.

GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma

Hu Li, A. Look, C. Ung, 2021, Cancer Research.

Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma

A. Look, T. Tao, G. Qing, 2021, Cancer Research.

p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage

Zhenhai Zhang, D. Lane, Zhao Ou, 2015, Cell Research.

Whole Genome Sequencing and CRISPR/Cas9 Gene Editing of Enterotoxigenic Escherichia coli BE311 for Fluorescence Labeling and Enterotoxin Analyses

T. Tao, Jia Hu, S. Lu, 2022, International journal of molecular sciences.

Targeting ganglioneuromas with mTOR inhibitors

A. Look, T. Tao, Adam D. Durbin, 2021, Molecular & cellular oncology.

Liver development in zebrafish (Danio rerio).

Jinrong Peng, T. Tao, Ting Tao, 2009, Journal of genetics and genomics = Yi chuan xue bao.

Def Functions as a Cell Autonomous Factor in Organogenesis of Digestive Organs in Zebrafish

Jinrong Peng, T. Tao, Delai Huang, 2013, PloS one.

A naturally occurring 4-bp deletion in the intron 4 of p53 creates a spectrum of novel p53 isoforms with anti-apoptosis function

Zhao Ou, Jinrong Peng, Jun Chen, 2014, Nucleic acids research.

Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitors

B. Lemos, A. Look, A. Gutierrez, 2020, The Journal of experimental medicine.

ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression

A. Look, T. Tao, B. Abraham, 2020, Science Advances.

Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies

K. Ross, A. Look, J. Aster, 2019, PLoS genetics.

Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state

R. Young, J. Joung, J. Maris, 2023, The Journal of clinical investigation.